Combination therapy is defined as a renin-angiotensin inhibitor and either a thiazide diuretic or a calcium channel blocker. For patients on combination therapy without obesity or obstructive sleep apnea, therapy with either a vasodilating β-receptor antagonist or an aldosterone receptor antagonist should be considered